Verily Seeks to Establish New COVID-19 ‘Baseline’ With Coronavirus Antibody Research Project

Source: FierceBiotech

Verily has launched a new clinical research effort focused on COVID-19 antibody testing and exploring the body’s immune response to the novel coronavirus, according to a FierceBiotech report.

Conducted under its Project Baseline endeavors, the life science-focused Google sibling said people who participate in the new studies could potentially help test new public health tools or future interventions. The program’s first initiative includes a serology study focused on those who previously received a swab-based COVID-19 exam through Verily’s earlier testing efforts in the San Francisco Bay Area.

Read the full article.

Related Content